Contemporary diagnosis and management of patients with adhesive small bowel obstruction Authors: Bonnie Du Cruz, Karyssa M Nelson, Carlos V R Brown Published: 2026 ABSTRACT AbstractAdhesive small bowel obstruction (aSBO) remains one of the most common causes of surgical admission and morbidity. With advancements in imaging and the advent of water-soluble contrast, management has become increasingly non-operative. Although this is successful in a majority of patients, patients who fail this trial without operation may face worse outcomes. Delays to surgical intervention are associated with increased rates of bowel ischemia, resection, infectious complications, and mortality. Optimal management therefore depends on early risk stratification, disciplined non-operative trials, and timely escalation to operation when indicated.This review summarizes contemporary evidence regarding pathogenesis, pathophysiology, epidemiology, diagnostic evaluation, management, and outcomes of aSBO, with a focus on practical decision-making. The evaluation of each patient’s obstruction consists of subjective clinical findings in combination with objective data including labs and imaging. CT with intravenous contrast remains a cornerstone of diagnosis, allowing identification of obstruction severity and features concerning for ischemic physiology that mandates immediate operative exploration. In the absence of these findings, a structured trial of non-operative management may be pursued, including nasogastric decompression, intravenous resuscitation, electrolyte correction, and inpatient admission with close oversight from a surgical team. Water-soluble contrast studies serve as both a prognostic and therapeutic adjunct, as failure of contrast to reach the colon within 24 hours is strongly predictive of unsuccessful non-operative management.Operative management should be undertaken promptly in patients with clinical deterioration, imaging evidence of ischemia, or failure of non-operative therapy. Although open laparotomy remains the standard approach, laparoscopy may be considered in carefully selected patients in experienced hands. Across management strategies, early surgical ownership and avoidance of prolonged non-operative trials in high-risk patients are critical to optimizing outcomes. aSBO is best managed through structured algorithms that prioritize early diagnosis, time-sensitive reassessment, and decisive operative intervention when indicated.Keywords: Intestine, Small; abdominal pain; Ischemia; peritonitis Introduction Adhesive small bowel obstruction (aSBO) remains the leading cause of mechanical small bowel obstruction (SBO) and a frequent indication for urgent surgical consultation. Although the majority of patients can be managed without immediate operative intervention, contemporary practice has shifted toward increasingly permissive non-operative strategies driven by advances in imaging, routine use of water-soluble contrast protocols, and guideline-supported observation periods. This evolution has sharpened the central clinical challenge in aSBO management: distinguishing patients who will benefit from continued non-operative therapy from those in whom operative delay confers preventable harm. Multiple studies demonstrate that delayed operative intervention is associated with higher rates of bowel resection, infectious complications, prolonged hospitalization, and mortality. These risks are not evenly distributed—disproportionately affecting elderly patients, those with significant comorbidities, and patients experiencing system-level delays to surgical care. As a result, management decisions in aSBO require more than algorithmic adherence, and rather, demand integration of imaging findings, physiologic trajectory, and institutional realities. This review focuses on contemporary surgical management of aSBO, with particular attention to diagnostic strategies related to operative timing and the consequences of delayed intervention. A nuanced understanding of the balance between non-operative success and the hazards of operative delay is essential to guide contemporary management of aSBO. Pathogenesis and pathophysiology In developed health systems, intra-abdominal adhesions account for the majority of SBO.1 2 Adhesion formation represents the dysregulation of normal peritoneal wound healing after surgical injury, inflammation, infection, or ischemia. Injury to the mesothelial surface initiates an inflammatory cascade characterized by fibrin deposition and fibroblast activation.3 4 Immediately after the insult, inflammation promotes temporary adhesion formation between parietal and visceral peritoneal surfaces. Under normal conditions, this fibrin matrix is degraded within 4–5 days via fibrinolysis, allowing for restoration of mesothelial integrity. Without timely, successful fibrinolysis, such as in cases of increased inflammation or ischemia, the fibrin matrix persists and organizes as collagen-secreting fibroblasts facilitate transformation into mature fibrous adhesions.5,7 Permanent acquired peritoneal adhesions are most commonly acquired after injury secondary to surgical trauma, resulting in persistence of physiologic fibrin deposition.5 Surgical factors that amplify inflammation, impair fibrinolysis due to decreased blood supply, and ultimately promote adhesion persistence include tissue ischemia, excessive cautery, contamination, or peritonitis. Meta-analyses estimate that aSBO develops in approximately 9% of patients after abdominal operation, with adhesions accounting for 65–75% of all SBO cases.1 2 Once established, adhesions cause obstruction through extrinsic compression, fixed angulation, or closed-loop configurations that predispose to strangulation or ischemia. The development of an obstruction may occur months to decades after the inciting operation and commonly recurs, although the greatest risk of SBO development is within the first 2 years after the inciting operation.8 Despite advances in understanding the molecular mechanisms of fibrosis, clinically effective prevention of adhesion formation remains limited, leaving operative technique as the primary modifiable factor.6 7 9 Consequently, outcomes after aSBO are driven not by prevention but by timely recognition and appropriate intervention once obstruction occurs. Epidemiology The risk of aSBO varies substantially based on operative approach, procedure type, patient characteristics, and health system factors. Surgical type and approach are the largest contributing risk factors for the development of aSBO, with laparoscopic approaches decreasing the risk of adhesion formation by 45%, although not eliminating the risk entirely.2 In general, procedures in the lower abdomen, pelvis, or both which result in damage to a large peritoneal surface area tend to put patients at a higher risk for subsequent SBO.5 Highest incidence has been documented for open adnexal operation (23.9%), followed by ileal pouch-anal anastomosis (19.3%), open total abdominal hysterectomy (15.6%), and open colectomy (9.5%).10 Although adhesions are common after abdominal operations, only a minority of patients (15–18%) progress to clinically significant obstruction requiring intervention.2 However, among those who do, outcomes vary widely. Elderly patients experience higher morbidity and mortality and often present later in the disease course and with less pronounced symptoms.11 It is reported that 21% of the elderly population suffered from chronic postoperative pain and 19% had pain-related functional impairment after operative management of aSBO, underscoring the need for careful goal-concordant discussions when discussing surgical management.12 Socio-economic and system-level disparities further influence care delivery: patients of minority race, lower insurance status, or limited access to surgical services are more likely to experience delayed operative intervention, a factor independently associated with worse outcomes.13,15 Hospital-level factors also have significant clinical impact: whereas rural hospitals demonstrate higher care costs, they are associated with lower odds of surgical delay and shorter lengths of stay, whereas cost reductions at urban centers appear to benefit white patients disproportionately.16 Importantly, populations at highest risk for morbidity and mortality, such as the elderly and socio-economically disadvantaged patients, are also the most likely to experience delays in operative intervention. Understanding these epidemiologic patterns is therefore essential to inform timely, individualized decision-making and to frame operative versus non-operative management decisions within the context of unequal risks of delay. Diagnostic evaluation Classification SBO is best conceptualized along several clinically relevant axes: cause, completeness, severity, and anatomic location. Adhesive obstruction represents a mechanical process distinct from functional ileus and must be differentiated from other causes of SBO that mandate operative intervention, including hernia, volvulus, neoplasm, gallstone ileus, and intussusception.17 The distinction between partial and complete obstruction, as well as identification of closed-loop physiology, carries prognostic and therapeutic implications.18 These features are most reliably determined through cross-sectional imaging and guide both the appropriateness and duration of non-operative management. Clinical presentation and initial evaluation The diagnostic evaluation of suspected aSBO begins in the emergency department with a focused history, physical examination, laboratory assessment, and early imaging to confirm the diagnosis, classify disease severity, and identify features that would warrant emergent operative intervention. Patients typically present with colicky abdominal pain, abdominal distension, nausea, vomiting, and obstipation. Symptoms may be intermittent or progressive depending on whether the obstruction is partial or complete. A focused history emphasizing prior abdominal or pelvic operations and previous episodes of SBO can inform cause and recurrence risk. Progression from intermittent to constant pain, systemic toxicity, or pain out of proportion to examination should raise concern for ischemia. Physical examination findings are often non-specific; however, identification of peritoneal signs, sepsis criteria, or hemodynamic instability should raise concern for bowel ischemia and prompt immediate operative consideration.19 A physical examination should also assess the underlying cause, such as palpating for an incarcerated abdominal wall or inguinal hernia.20 In addition to focused history, physical examination, and vitals, laboratory values may aid in narrowing the differential and assessing for ischemia. Leukocytosis, metabolic acidosis, and high lactate levels may further support the presence of systemic toxicity due to bowel ischemia but should be interpreted in clinical context rather than in isolation.18 Kidney function should be assessed and may also guide initial resuscitative efforts prior to intravenous contrast administration for imaging studies. Additionally, electrolyte imbalances should guide fluid resuscitation, as hypokalemic, hyperchloremic metabolic alkalosis is common due to frequent vomiting in this presentation. Imaging CT with intravenous contrast is the diagnostic modality of choice in suspected SBO. Traditionally, three-view plain abdominal radiograph series were the most common imaging modality to confirm the diagnosis of SBO, with the literature reflecting a sensitivity of 66–85%.18 Due to the low cost and speed associated with plain radiographs, they may have some role in the initial diagnostic work-up of SBO. Findings suggestive of SBO include dilated gas-filled or fluid-filled loops of bowel and a non-distended colon, although the severity of SBO may be underestimated on abdominal radiograph. Perforation may additionally be assessed using upright films.18 However, more recent literature and the widespread availability of CT have established CT scans as the gold standard for imaging in the diagnosis of SBO, with greater than 90% sensitivity and specificity.19 20 The use of plain radiographs is thus largely limited to initial screening or serial follow-up imaging when warranted. In concordance with this, current recommendations supported with Level I evidence from the Eastern Association for the Surgery of Trauma (EAST) include CT abdomen/pelvis for all patients with SBO to provide information about grade, severity, and cause.20 CT with intravenous contrast is used for reliable diagnosis of SBO and bowel perfusion.18 20 Common CT findings include a transition point with proximal dilation of bowel and distal decompression (figure 1); a decompressed colon; and if PO contrast is given prior to CT scan, the lack of contrast beyond the transition point. Coronal contrast-enhanced CT image of the abdomen demonstrating a transition point (arrow) with dilated proximal small bowel loops and distal bowel decompression. The level of obstruction, underlying cause, and presence of ischemia should also be assessed using CT scans. Findings consistent with closed loop obstruction, such as a solid tissue mass and “whirl sign”, should be assessed to guide clinical decision making. The whirl sign, which is described as a swirl of mesenteric soft tissue and fat attenuation with adjacent loops of bowel surrounding rotated mesenteric vessels, has been reported to be associated with a 25-fold increased likelihood of requiring surgical management.21 However, more recent retrospective studies have found that non-operative management may be increasingly successful even in those with what appears to be a closed-loop SBO on imaging (59% of cases), adding to the controversy of operative versus non-operative management and the impact of timing on clinical decision making, discussed in the management section of this review.22 Regardless of the type and extent of obstruction, CT scan findings should be used to analyze whether bowel ischemia, a surgical emergency, is present. Reduced bowel wall enhancement is the most reliable imaging predictor of ischemia with over 95% sensitivity and a 99% negative predictive value, which correlates strongly with the need for bowel resection.17 19 Additional findings consistent with ischemia include bowel wall thickening (>3 mm), mesenteric venous congestion, mesenteric edema or stranding, unusual course of the mesenteric vasculature, pneumatosis, and ascites (figure 2).17 20 Axial contrast-enhanced CT image demonstrating pneumatosis intestinalis (arrows) in a patient with adhesive small bowel obstruction. The diagnostic evaluation of suspected SBO up to this point should focus on identifying the need for emergency surgical intervention as opposed to a trial of non-operative management, as strangulation resulting in ischemia is the main source of morbidity and mortality in patients with aSBO (table 1).17 There is no single consensus or criteria for determining the presence of bowel ischemia, and instead, physicians must rely on a constellation of findings throughout the diagnostic evaluation. The initial goals of work-up should therefore include immediate identification of hemodynamic instability, the presence of mesenteric ischemia, and the need for operative intervention, which should occur in concert with initial resuscitation. Table 1Predictors of bowel ischemia and subsequent failure of non-operative management in aSBODiagnostic modalityFindings concerning for bowel ischemiaPhysical examinationPersistent or worsening abdominal pain; peritoneal signs; fever or systemic signs of sepsis; hemodynamic instabilityLaboratory findingsLeukocytosis; elevated serum lactate; metabolic acidosisImaging Plain filmPneumoperitoneum on upright radiography CT scanReduced bowel wall enhancement; bowel wall thickening; bowel edema; mesenteric fluid; distended or congested mesenteric vasculature; pneumatosis; ascitesaSBO, adhesive small bowel obstruction. Predictors of bowel ischemia and subsequent failure of non-operative management in aSBO aSBO, adhesive small bowel obstruction. For patients without evidence of ischemia, water-soluble contrast studies provide both diagnostic and prognostic value. Water-soluble contrast agents (WSCA) such as gastrografin (GG) are administered orally or via nasogastric tube (NGT) and can be identified on plain film radiographs (figure 3). Diagnostically, passage of the contrast into the colon within 24 hours on serial imaging predicts the resolution of the aSBO without operative management with 96% sensitivity and 98% specificity (figure 4).23 EAST practice management guidelines24 provide Level II evidence recommending WSCA such as GG in partial SBO as it is both diagnostic and therapeutic and can improve bowel function, measured as time to bowel movement, as well as decrease hospital length of stay. (a) Plain abdominal radiograph after immediate administration of water-soluble contrast. (b) Follow-up abdominal radiograph of the same patient demonstrating progression of contrast into the colon within 24 hours, consistent with successful non-operative management. SBFT, Small bowel follow-through. Plain abdominal radiograph obtained 8 hours after administration of water-soluble contrast with failure of contrast to progress into the colon and persistent opacification of dilated small bowel. SBFT, Small bowel follow-through. Management Initial resuscitation Management of aSBO is guided by early identification of patients requiring immediate operative intervention versus those appropriate for a structured trial of non-operative management, incorporating clinical assessment, CT findings, and WSCA (figure 5). Regardless of the presence of ischemic findings, however, all patients should undergo initial resuscitative efforts alongside the diagnostic evaluation period. All patients with suspected aSBO should be admitted for inpatient management, with patients admitted to a surgical service—as opposed to a medical service. Surgically managed patients have fewer delays in treatment and improved clinical outcomes.25 26 Algorithm for the evaluation and management of aSBO. aSBO, adhesive small bowel obstruction; NGT, nasogastric tube. *Open laparotomy is standard of care. Laparoscopy may be considered by experienced surgeons for select patients with limited prior abdominal surgery (≤2 laparotomies), or a single adhesive band is expected. ROBF, Return of bowel function. Initial management prioritizes hemodynamic stabilization, volume resuscitation, and correction of electrolyte abnormalities resulting from third spacing and emesis. Intravenous isotonic crystalloid resuscitation with lactated Ringer solution or normal saline should be initiated promptly, with electrolyte repletion as indicated. Potassium repletion, in particular, may be required due to hypochloremic hypokalemic metabolic alkalosis secondary to emesis. Patients should be maintained nil per os both to limit further bowel distension and to reduce aspiration risk in the case of urgent surgical intervention.18 Gastrointestinal decompression with an NGT provides symptomatic relief, particularly in patients with high-grade obstruction or significant emesis, though its impact on overall outcomes is variable.24 27 Recent studies have found that for aSBO specifically, those with NGT decompression exhibited poorer outcomes than those without, although this may be accounted for with selection bias in that patients receiving gastrointestinal decompression tend to be those with higher disease severity and greater abdominal distension.28 Use of NG decompression may be individualized based on symptom burden and disease severity, but in the large majority of cases, NG tube decompression should be used to prevent further bowel distension. In patients with concern for ischemia, perforation, or systemic infection, broad-spectrum antibiotics should be initiated promptly, and operative source control pursued without delay. Non-operative versus operative management After initial resuscitation, surgeons must first decide if the patient warrants urgent operative management. Patients with signs of strangulation and ischemia should be taken to the operating room. Clinically, these factors include peritonitis, fever, and hemodynamic instability. In laboratory evaluation, leukocytosis and an elevated lactate raise concern. Radiographic findings including pneumoperitoneum, free fluid, pneumatosis intestinalis, small bowel with no enhancement, or closed-loop obstruction should prompt urgent operative intervention. Patients without signs of bowel ischemia can follow a non-operative management strategy, which has up to a 90% success rate. Standard therapy includes bowel rest, NG decompression, intravenous fluid resuscitation, electrolyte correction, and close clinical observation. Water-soluble contrast is an important diagnostic and therapeutic tool in the non-operative management of adhesive SBO. Contrast is delivered typically via NG tube after initial decompression (or orally if the patient refuses NG tube placement). The progression of the contrast is then followed with plain film radiographs. The timing of contrast delivery and subsequent films varies by institution. Obstruction will resolve in 99% of patients where contrast reaches the colon in 4–24 hours. When contrast does not reach the colon, the obstruction is unlikely to resolve without an operation in 90% of patients.23 Therapeutically, the hyperosmotic property of these agents draws edema in the bowel wall into the lumen, aiding in the resolution of the obstruction.29 Multiple studies and meta-analyses have demonstrated that the use of water-soluble contrast is associated with shorter time to resolution, reduced hospital length of stay, and improved confidence in patient selection for non-operative management. When comparing patients that underwent an initial contrast challenge against those that did not, there were lower rates of bowel resection, need for surgical exploration, and shorter hospital stays, but there was a longer duration from admission to operative exploration for those that did ultimately require operation. Overall, the use of water-soluble contrast as a tool in the evaluation and non-operative management of SBO is safe, with a low rate of missed strangulation.29 Importantly, contrast administration should be viewed as a complement to careful clinical assessment rather than a replacement for it, and its use should not delay operative intervention in patients with clinical deterioration. For patients without frank signs of deterioration, a set time limit for non-operative management should be defined. Contemporary guidelines by the EAST recommend 3–5 days,24 and the World Society of Emergency Surgery recommends 3 days.30 Both recommend evaluation of contrast progression at 48 and 24 hours respectively. The timing of operation is critical to the outcomes of patients. Failure of contrast to progress through the obstruction to the large bowel, usually within 24 hours, should prompt consideration of operative intervention. Delayed intervention in patients with evolving ischemia is associated with increased rates of bowel resection, postoperative complications, and mortality. The integration of CT findings, water-soluble contrast progression, and serial clinical examinations allows for more informed and timely operative decision-making. Surgical technique and approaches The goal of surgical intervention is to alleviate obstruction via adhesiolysis and minimizing additional trauma and injury. Open exploratory laparotomy remains the standard operative approach for aSBO. Laparoscopic or robotic adhesiolysis may be considered in carefully selected patients, particularly when the surgeon has sufficient experience, the patient has limited prior abdominal operation (≤2 laparotomies), or a single adhesive band is expected.30 Minimally invasive approaches can reduce postoperative pain, length of stay, wound complications, and incidence of adhesion-related readmissions.31 However, the risk of enterotomy remains significant, with a higher incidence in laparoscopic cases.32 When visualization is inadequate or dense adhesions are encountered, early conversion to open operation is recommended. Regardless of open or minimally invasive surgical approach, the small bowel should be examined from the Ligament of Treitz to the terminal ileum to identify a transition point. In cases where extensive adhesions are encountered, dissection should be focused on the primary area of obstruction, as unnecessary adhesiolysis increases the risk of iatrogenic injury. Sharp dissection with minimal electrocautery should be prioritized. Patients requiring operative intervention for aSBO frequently present with marked dilation of small bowel proximal to the point(s) of obstruction. Venous outflow obstruction can progress to frank ischemia, demanding bowel resection. Intraoperatively, ischemic bowel may appear discolored as purple, gray, or, in severe cases, pale and yellow (figure 6). If the necrosis has progressed, perforation may be present. Clearly non-viable or perforated segments should be resected. After relieving the adhesive obstruction, bowel segments of questionable viability should be reassessed. Perfusion may improve, evidenced by the bowel “pinking up,” during the course of the operation. (a) Intraoperative photograph demonstrating a discrete ischemic small bowel segment encountered during exploratory laparotomy for adhesive small bowel obstruction. (b) Intraoperative photograph demonstrating non-viable bowel segment necessitating segmental resection. When bowel viability remains questionable, a planned second-look operation is appropriate, particularly in critically ill or hemodynamically unstable patients.33 In these cases, ischemic segments should be resected and the patient left in discontinuity with temporary abdominal closure until reassessment. Patients should be adequately resuscitated and stabilized prior to reoperation, at which time definitive resection should be performed if viability remains questionable or compromised (Figure 7).33 The utility of second-look operations remains a controversial decision due to higher mortality in take-back patients, although this may be attributed to worse severity of disease at initial presentation.34 Surgical revision should therefore be individualized to the patient in the context of preoperative and perioperative findings. Assessment of small bowel perfusion before and after indocyanine green (ICG) fluorescence utilization intraoperatively (A) Gross inspection of a segment of bowel during a scheduled return to the operating room for questionable bowel perfusion (B) Fluorescence imaging following intravenous ICG administration demonstrating intact perfusion of the same bowel segment, evidenced by uniform fluorescence. Indocyanine green (ICG) fluoroscopy is an additional method to evaluate bowel viability beyond simple gross examination. In this technique, ICG is suspended in sterile water and administered intravenously (typically 25 mg of ICG powder suspended in 10 mL of sterile water).35 Handheld, laparoscopic, or robotic fluorescein imaging devices are then used to assess bowel perfusion (figure 7). The presence and pattern of arterial perfusion of the segment in question are compared with healthy bowel; clearance of the dye may assist in evaluation of venous drainage.35 Regardless of adjunctive tools, careful intraoperative judgment and ongoing postoperative surveillance remain essential, particularly when bowel viability is equivocal. Serial assessments should be provided to analyze progressive ischemia, with the continued goal of definitive management for adequate source control. Postoperative care and recurrence prevention After operation, management should focus on early mobilization, multimodal analgesia, and judicious fluid administration to minimize ileus and facilitate recovery. Enhanced recovery principles may be applied selectively, although their role in emergency operation continues to evolve. Recurrence of SBO remains a significant concern, and patients should be counseled regarding the ongoing lifetime risk of future obstruction. Adhesion prevention strategies, including meticulous surgical technique and the selective use of adhesion barrier agents, may reduce adhesion formation, although evidence for routine use in emergency operation is mixed. No intervention completely eliminates the risk of recurrence, reinforcing the importance of individualized decision making and patient education. Outcomes Although most patients can be successfully managed non-operatively, there is increased risk of morbidity and mortality in those with missed ischemia and strangulation. Initial non-operative management in patients with a complete obstruction will lead to bowel resection in 30% of cases.24 With increasing delay from admission to time of laparotomy, there is increased risk of severe complications including surgical site infections, pneumonia, and sepsis. In addition, there is an associated increase in length of stay and mortality. Patients more likely to undergo delayed operations include those that are elderly, have multiple comorbidities, have low functional status, or are of low socio-economic background.36 Admission to a primary surgical team may combat these factors, as studies have demonstrated a decreased time to operation and overall hospital stay.26 Although the decision to operate should be made early in a patient’s clinical course, around the 24-hour mark, procedures done “after hours” may be associated with higher adverse outcomes.36 This is likely secondary to patient factors, as those requiring emergent intervention have progressed to ischemia at this point. Conclusions and recommendations aSBO remains a common and clinically significant surgical problem, in which outcomes are analyzed less by availability of therapeutic options than by the timing and quality of surgical decision-making. Although non-operative management is appropriate and successful in the majority of patients without evidence of strangulation, its use must be deliberate, time-limited, and continuously reassessed. WSCA has become a critical adjunct in this process, offering both prognostic clarity and therapeutic benefit, and should be incorporated routinely in patients undergoing a trial of non-operative management. In addition to diagnostic and therapeutic insights, WSCA has been seen in studies to shorten hospital stays and reduce the need for operative intervention. Patients presenting with peritonitis, sepsis, hemodynamic instability, or radiographic findings concerning for ischemia or closed-loop obstruction require immediate operative intervention. In the absence of these features, a structured non-operative trial can be pursued when supported by serial clinical examinations, CT findings, and contrast progression. Failure of contrast to reach the colon within 24 hours should prompt consideration of operative management, as continued delay beyond this window is consistently associated with increased rates of bowel resection, infectious complications, prolonged hospitalization, and mortality. Although contemporary guidelines allow for up to 3–5 days of non-operative management in carefully selected patients, the decision to operate should be made early, with execution guided by individual patient course and trajectory rather than arbitrary time thresholds. Operative intervention, when indicated, should prioritize relief of obstruction with minimal additional iatrogenic injury. Open laparotomy remains the standard approach, particularly in patients with dense adhesions or multiple prior operations. Minimally invasive adhesiolysis may be considered in select patients with favorable clinical profiles and in the hands of experienced surgeons, offering potential benefits in recovery and recurrence, but should be approached with a low threshold for conversion to open. Importantly, delays in operative management disproportionately affect elderly, medically complex, and socio-economically disadvantaged populations—groups that already bear a higher risk of complications at baseline. Admission under a primary surgical service and early surgical ownership of decision-making are associated with shorter time to intervention and improved outcomes. Operation at the index admission, when indicated, also appears to reduce long-term recurrence risk and should be considered part of definitive management rather than a failure of non-operative care. In summary, optimal management of aSBO requires disciplined non-operative trials, early identification of failure, and timely operative management. Surgeons must balance the benefits of avoidance of operation against the very real harms of delay, using imaging, contrast studies, and serial examination to guide decisive action. As non-operative strategies continue to evolve, the central determinant of outcome remains sound surgical judgment applied early in the disease course. Overall, individualized management balancing patient risk factors, clinical findings, and system-level considerations is essential to optimize outcomes in aSBO and prevent surgical delay for patients that warrant surgical intervention. Ethics approval and funding statement This article is a narrative review and educational synthesis of previously published literature. It did not involve human participants or animal subjects, and no individual-level data were collected or analyzed. The article includes representative diagnostic imaging and intraoperative photographs used for educational purposes only. All images were fully de-identified and contain no personal or protected health information, and no individual is identifiable. As a result, institutional review board or ethics committee approval was not required, and informed consent was not applicable. We have no disclosures, no conflicts of interest, and no outside financial support for our research. Footnotes Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors. Patient consent for publication: Not applicable. Ethics approval: Not applicable. Provenance and peer review: Commissioned; externally peer reviewed. References